Ciphergen Biosystems(CIPH): Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ciphergen Biosystems(CIPH):

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (267)	9/6/2004 6:47:41 PM
From: tuck	of 510

>>Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay.<< Full text freebie, so hot off the press it hasn't been fully edited yet: proteomesci.com Sounds esoteric ut is not that hard to understand. Underscores the advantage of SELDI over ELISA. Also underscores the lack of market penetration by BioSepra's MEP sorbent that seems superior to Protein A. The authors obtained the latter from the German branch of Sigma. Maybe the shipping cost of MEP didn't justify other savings? Maybe MEP is sufficiently more expensive that the added time and expense of another buffering step are worth using Protein A? I have no idea. I would like to see more progress in marketing this product. Hey, Ciphergen guys, if you're lurking . . . why not talk to these fellas about it? Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next